SCHEMBL5799690

SCHEMBL5799690

CSc1nccc(-c2c(-c3ccc(F)cc3)nn3ccccc23)n1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 10/20 0.57
GSK3B P49841 4/20 0.57
EGFR P00533 1/20 0.57
RAF1 P04049 1/20 0.57
ADORA3 P0DMS8 1/20 0.57
ADORA2A P29274 1/20 0.57
ADORA2B P29275 1/20 0.57
ADORA1 P30542 1/20 0.57
CSNK1E P49674 2/20 0.50
CCNA2 P20248 1/20 0.50
CDK2 P24941 1/20 0.50
CDK5 Q00535 1/20 0.50
CDK5R1 Q15078 1/20 0.50
TGFBR1 P36897 2/20 0.47
TGFBR2 P37173 1/20 0.47
CSNK1D P48730 2/20 0.46
JAK3 P52333 1/20 0.46
POLB P06746 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14593090 0.91 MAPK14 (0.49) MAPK14GSK3BEGFRRAF1ADORA3
SCHEMBL14627004 0.88 MAPK14 (0.54) MAPK14GSK3BEGFRRAF1ADORA3
SCHEMBL5208955 0.88 MAPK14 (0.45) MAPK14GSK3BEGFRRAF1ADORA3
SCHEMBL5210526 0.87 TGFBR1 (0.50) MAPK14GSK3BEGFRRAF1ADORA3
SCHEMBL5798463 0.87 GSK3B (0.48) MAPK14GSK3BEGFRRAF1ADORA3
SCHEMBL5384464 0.83 MAPK14 (0.60) MAPK14GSK3BEGFRRAF1ADORA3
SCHEMBL5800758 0.81 MAPK9 (0.39) MAPK14GSK3BEGFRRAF1ADORA3
SCHEMBL5385825 0.81 MAPK14 (0.60) MAPK14GSK3BCSNK1ECCNA2CDK2
SCHEMBL13848066 0.81 TGFBR1 (0.42) MAPK14GSK3BEGFRRAF1ADORA3
SCHEMBL5383803 0.81 MAPK14 (0.58) MAPK14GSK3BEGFRRAF1ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7166597-B2 Fused pyrazole derivatives being protein kinase inhibitors GLAXO GROUP LIMITED (GB) 2007-01-23 US disclosed
US-7166597-B2 Fused pyrazole derivatives being protein kinase inhibitors GLAXO GROUP LIMITED (GB) 2007-01-23 US disclosed
WO-2006055245-A2 PROCESS FOR PREPARING PYRAZOLOPYRIDINE COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2006-05-26 WO disclosed